
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI
[ Thu, Oct 05th 2017 ]: WOPRAI

[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI
[ Wed, Oct 04th 2017 ]: WOPRAI

[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI
[ Tue, Oct 03rd 2017 ]: WOPRAI

[ Mon, Oct 02nd 2017 ]: WOPRAI
[ Mon, Oct 02nd 2017 ]: WOPRAI
[ Mon, Oct 02nd 2017 ]: WOPRAI
[ Mon, Oct 02nd 2017 ]: WOPRAI
Douglas Tsao Maintained (TEVA) at Hold with Decreased Target to $21 on, Oct 4th, 2017


🞛 This publication is a summary or evaluation of another publication
Douglas Tsao of Barclays, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Decreased Target from $23 to $21 on, Oct 4th, 2017.
Douglas has made no other calls on TEVA in the last 4 months.
There are 10 other peers that have a rating on TEVA. Out of the 10 peers that are also analyzing TEVA, 6 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
- Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
- Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
- Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017
These are the ratings of the 4 analyists that currently disagree with Douglas
- Tim Chiang of "BTIG" Upgraded from Hold to Strong Buy and Held Target at $24 on, Monday, September 11th, 2017
- Vamil Divan of "JMP Securities" Maintained at Sell with Increased Target to $14 on, Wednesday, September 6th, 2017
- David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $16 on, Monday, August 7th, 2017
- Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017
Similar Stocks and Investing Publications
[ Mon, Sep 11th 2017 ]: WOPRAI
[ Wed, Sep 06th 2017 ]: WOPRAI
[ Thu, Aug 24th 2017 ]: WOPRAI
[ Wed, Aug 16th 2017 ]: WOPRAI
[ Mon, Aug 07th 2017 ]: WOPRAI
[ Mon, Aug 07th 2017 ]: WOPRAI
[ Fri, Jul 14th 2017 ]: WOPRAI
[ Thu, Jul 13th 2017 ]: WOPRAI
[ Tue, Jul 11th 2017 ]: WOPRAI
[ Fri, Jun 09th 2017 ]: WOPRAI
[ Thu, May 11th 2017 ]: WOPRAI
[ Wed, Nov 16th 2016 ]: WOPRAI